I am pleased to introduce Intuitive’s 2025 Corporate Impact Report.
I started with Intuitive in March 1996 as a mechanical engineer responsible for designing several aspects of our first-generation system. My first months were spent in the lab and operating room trying to understand what was required to perform high-quality minimally invasive surgery and how robotics could possibly move the field forward.
In those days, I had the privilege to be able to “scrub in” to cases—working shoulder-to-shoulder with surgeons and nurses to apply this new robot to a variety of cases, including cardiac surgery. It was in these earliest days at Intuitive that I quickly understood that we could occupy a privileged position in both medical technology and healthcare. We could develop and deliver some of the most advanced technology in the world and intersect that innovation with a very human purpose: patient care.
This privileged position is one that carries significant responsibility. The hospitals and healthcare systems we work with rely on our products to be safe, effective, and reliable. A foundational part of our work is understanding what customers care about—working side by side with them to ensure what we are doing matters and solves their problems.
Our mission is directly aligned with our customers’ pursuit of the Quintuple Aim: better outcomes, an enhanced patient experience, improving care team experience, lowering the total cost of care, and expanding access to care. It is the framework that guides our work and how we measure ourselves through our corporate impact. By anchoring our goals and expectations to what matters most to our customers, we can position the company for success.
You’ll learn more about how we define and measure our impact on the global healthcare communities we serve in Intuitive’s 2025 Corporate Impact Report. This year, I’m proud to highlight the following:
Impact on physicians and care teams
In 2025, we reached an incredible milestone—more than 20.4 million cumulative procedures using our technology since the first patient underwent a procedure in 1997. This year alone, over 3.2 million procedures were performed across our da Vinci 5, Single Port, and Ion platforms with an installed base of more than 12,000 systems.
We expanded our da Vinci and Ion systems into more geographies and secured additional clinical clearances around the world—delivering products and services that are helping solve the pressing challenges physicians and care teams care most about.
Da Vinci 5, the most integrated and advanced system we’ve ever created, moved from a limited U.S. release to a full global launch, and we introduced new features and capabilities along the way. These advancements include Force Feedback and Force Gauge to improve outcomes and insights, integrated insufflation to enhance surgeon autonomy, and new instrumentation and 3D modeling to improve procedure efficiency.
We also made advancements with Ion, our bronchoscopic platform, with the goal of improving the survivability of lung cancer. We believe there is great opportunity to shorten the general care pathway from detection to treatment by continuing to build on Ion’s core capabilities. We are investing in areas such as real-time tissue assessment and focal therapies to streamline the care pathway and compress what can be a 200-day patient journey to less than a month.
Our digital journey is also important. Platform growth and expansion are enabled by a foundational digital ecosystem. We are now receiving data from more than 1,000 cases a day. This information allows our data scientists to identify meaningful insights and make them actionable by delivering them to clinicians through training, simulation, and mentorship facilitated by telecollaboration tools.
Impact on patients
We deeply believe in a future where all patients have access to high-quality care, regardless of where they are or when they need it.
Although we have made great progress, we are only at the beginning. We believe there is significant opportunity to expand access to our technology for physicians and their patients who may currently be underserved. To support this, we are generating research that describes existing disparities in access to minimally invasive care (MIC) and helps identify barriers and inform solutions to expand access. This data, bundled with our advanced technology such as telecollaboration and our expansion into new indications and geographies, could increase our potential to reach millions more patients in the future.
Impact on our communities and people
Innovation takes many forms—from how our products and services improve MIC, to our ability to manufacture at the highest quality at scale, to how we analyze data and communicate it to physicians and care teams to enhance patient care, and to our employee programs that enable our staff to grow their careers in support of our mission.
We now have more than 17,000 talented employees in countries around the world who are committed to living our values, transforming healthcare, and making a difference for customers, care teams, and communities worldwide. It is this collective passion that drives us to truly understand what our customers care about.
At our core, innovation is driven by delivering value in areas where we can have a meaningful impact on physicians and their patients. It is this mission-driven impact that we believe is transforming healthcare.
Dave Rosa
Chief Executive Officer